DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Barf T, Vallgarda J, Emond R, Haggstrom C, Kurz G, Nygren A, Larwood V, Mosialou E, Axellson K, Olsson R, Engblom L, Edling N, Rönquist-Nii Y, Ohman B, Alberts P, Abrahmsen L.
Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.
J Med Chem 2002; 45: 3813-3815
We do not assume any responsibility for the contents of the web pages of other providers.